TASK C14: SCALE UP FERMENTATION AND ISOLATION OF MEDINAMYCIN

NIH RePORTER · NIH · N01 · $554,127 · view on reporter.nih.gov ↗

Abstract

To facilitate preclinical product development of promising therapeutics for infectious disease-causing pathogens and/or toxins. Services include: preclinical product development planning and evaluation; lead identification and development; chemistry and GMP manufacturing; in vitro and in vivo preclinical microbiological, safety, toxicology and pharmacokinetics.

Key facts

NIH application ID: 10655909
Project number: 272201800008I-0-759302200001-1
Recipient: ALBANY MOLECULAR RESEARCH, INC.
Principal Investigator: JIANXIE CHEN
Activity code: N01
Funding institute: NIH
Fiscal year: 2022
Award amount: $554,127
Award type: —
Project period: 2022-01-03 → 2022-12-31